Reports
Global Exocrine Pancreatic Insufficiency Treatment Market: By Disease Management: Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Others; By Diagnosis; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments
Global Exocrine Pancreatic Insufficiency Treatment Market Outlook
The global exocrine pancreatic insufficiency treatment market attained a value of more than USD 3.6 billion in 2021. The market is further expected to grow at a CAGR of 8.27% during the forecast period of 2023-2028 to reach above USD 5.8 billion by 2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Prevalence of EPI Causing Disorders is Aiding the Market Growth of Exocrine Pancreatic Insufficiency Treatment
The global market for exocrine pancreatic insufficiency treatment is being driven by the increasing prevalence of chronic pancreatic and cystic fibrosis amongst the geriatric populations. In addition, cystic fibrosis has been increasingly found in young children and people in early adulthood, leading to a rise in the number of people suffering from exocrine pancreatic insufficiency, and hence augmenting the demand for an effective treatment, thereby contributing to the market growth.
Furthermore, owing to sedentary lifestyles and unhealthy eating habits, the spur in the global cases of diabetes is a leading cause of exocrine pancreatic insufficiency. However, increasing awareness regarding the impact of exocrine pancreatic insufficiency on human health resulting in disturbances in normal growth, reduced life expectancy, and lowered immunity levels have stimulated the growth of the market.
Exocrine Pancreatic Insufficiency Treatment: Market Segmentation
Exocrine pancreatic insufficiency (EPI) refers to a medical condition characterised by the inability to properly digest food due to insufficient levels of digestive enzymes produced by pancreas. The disease is most commonly detected by clinical tests such as blood, stool, malabsorption, and pancreatic function tests. Exocrine pancreatic insufficiency treatment includes all types of disease management to help the patient recover from exocrine pancreatic insufficiency.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of disease management, the market can be divided into:
- Nutritional Management
- Pancreatic Enzyme Replacement Therapy (PERT)
- Lifestyle Modifications approach
Based on diagnosis, the market can be segmented into:
- Magnetic Resonance Imaging (MRI)
- CT Scanning
- Endoscopic ultra-sonography (EUS)
- Blood Tests
- Others
The EMR report looks into the regional markets of exocrine pancreatic insufficiency treatment like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Pharmaceutical Investments in R&D Activities to Augment the Market Growth of Exocrine Pancreatic Insufficiency Treatment
The rising focus on pharmaceutical research and development (R&D) for an effective treatment method is significantly contributing to the overall growth of the market. In order to address the increasing demand for the treatment of exocrine pancreatic insufficiency, key industry players, in conjunction with governing agencies, are significantly contributing towards the development of a cure, hence pushing the growth of the market. In addition to this, the strong market penetration of significant pipeline drugs is further substantially contributing to the overall market growth of exocrine pancreatic insufficiency treatment. Moreover, the emergence of new chemical entities (NCEs) in different parts of the world and rising focus on nutritional diet are expected to have a positive influence on the market growth in the coming years.
Key Industry Players in the Global Exocrine Pancreatic Insufficiency Treatment Market
The report presents a detailed analysis of the following key players in the global exocrine pancreatic insufficiency treatment market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:
- AbbVie Inc.
- Janssen Global Services, LLC
- Chiesi Farmaceutici S.p.A.
- Nordmark Arzneimittel GmbH and Co. KG
- Digestive Care, Inc
- Cilian AG
- Anthera Pharmaceuticals, Inc.
- Allergan plc.
- First Wave BioPharma, Inc. (AzurRx)
- Aptalis Pharma Inc.
- Others
The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Disease Management, Diagnosis, Region |
| Breakup by Disease Management | Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Lifestyle Modifications approach |
| Breakup by Diagnosis | Magnetic Resonance Imaging (MRI), CT Scanning, Endoscopic ultra-sonography (EUS), Blood Tests, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | AbbVie Inc., Janssen Global Services, LLC, Chiesi Farmaceutici S.p.A., Nordmark Arzneimittel GmbH and Co. KG, Digestive Care, Inc, Cilian AG, Anthera Pharmaceuticals, Inc., Allergan plc., First Wave BioPharma, Inc. (AzurRx), Aptalis Pharma Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Exocrine Pancreatic Insufficiency Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Exocrine Pancreatic Insufficiency Treatment Historical Market (2018-2022)
8.3 Global Exocrine Pancreatic Insufficiency Treatment Market Forecast (2023-2028)
8.4 Global Exocrine Pancreatic Insufficiency Treatment Market by Disease Management
8.4.1 Nutritional Management
8.4.1.1 Historical Trend (2018-2022)
8.4.1.2 Forecast Trend (2023-2028)
8.4.2 Pancreatic Enzyme Replacement Therapy (PERT)
8.4.2.1 Historical Trend (2018-2022)
8.4.2.2 Forecast Trend (2023-2028)
8.4.3 Lifestyle Modifications approach
8.4.3.1 Historical Trend (2018-2022)
8.4.3.2 Forecast Trend (2023-2028)
8.5 Global Exocrine Pancreatic Insufficiency Treatment Market by Diagnosis
8.5.1 Magnetic Resonance Imaging (MRI)
8.5.1.1 Historical Trend (2018-2022)
8.5.1.2 Forecast Trend (2023-2028)
8.5.2 CT Scanning
8.5.2.1 Historical Trend (2018-2022)
8.5.2.2 Forecast Trend (2023-2028)
8.5.3 Endoscopic ultra-sonography (EUS)
8.5.3.1 Historical Trend (2018-2022)
8.5.3.2 Forecast Trend (2023-2028)
8.5.4 Blood Tests
8.5.4.1 Historical Trend (2018-2022)
8.5.4.2 Forecast Trend (2023-2028)
8.5.5 Others
8.6 Global Exocrine Pancreatic Insufficiency Treatment Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2022)
8.6.3.2 Forecast Trend (2023-2028)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2022)
8.6.4.2 Forecast Trend (2023-2028)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2022)
8.6.5.2 Forecast Trend (2023-2028)
9 North America Exocrine Pancreatic Insufficiency Treatment Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
10 Europe Exocrine Pancreatic Insufficiency Treatment Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2022)
10.1.2 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Historical Trend (2018-2022)
10.2.2 Forecast Trend (2023-2028)
10.3 France
10.3.1 Historical Trend (2018-2022)
10.3.2 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Historical Trend (2018-2022)
10.4.2 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Exocrine Pancreatic Insufficiency Treatment Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2022)
11.1.2 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Historical Trend (2018-2022)
11.2.2 Forecast Trend (2023-2028)
11.3 India
11.3.1 Historical Trend (2018-2022)
11.3.2 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Historical Trend (2018-2022)
11.4.2 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Historical Trend (2018-2022)
11.5.2 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Exocrine Pancreatic Insufficiency Treatment Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2022)
12.1.2 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Historical Trend (2018-2022)
12.2.2 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Historical Trend (2018-2022)
12.3.2 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Exocrine Pancreatic Insufficiency Treatment Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2022)
13.1.2 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2022)
13.2.2 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Historical Trend (2018-2022)
13.3.2 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Historical Trend (2018-2022)
13.4.2 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 AbbVie Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Janssen Global Services, LLC
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Chiesi Farmaceutici S.p.A.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Nordmark Arzneimittel GmbH and Co. KG
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Digestive Care, Inc
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Cilian AG
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Anthera Pharmaceuticals, Inc.
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Allergan plc.
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 First Wave BioPharma, Inc. (AzurRx)
15.2.9.1 Company Overview
15.2.9.2 Product Portfolio
15.2.9.3 Demographic Reach and Achievements
15.2.9.4 Certifications
15.2.10 Aptalis Pharma Inc.
15.2.10.1 Company Overview
15.2.10.2 Product Portfolio
15.2.10.3 Demographic Reach and Achievements
15.2.10.4 Certifications
15.2.11 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Exocrine Pancreatic Insufficiency Treatment Market: Key Industry Highlights, 2018 and 2028
2. Global Exocrine Pancreatic Insufficiency Treatment Historical Market: Breakup by Disease Management (USD Billion), 2018-2022
3. Global Exocrine Pancreatic Insufficiency Treatment Market Forecast: Breakup by Disease Management (USD Billion), 2023-2028
4. Global Exocrine Pancreatic Insufficiency Treatment Historical Market: Breakup by Diagnosis (USD Billion), 2018-2022
5. Global Exocrine Pancreatic Insufficiency Treatment Market Forecast: Breakup by Diagnosis (USD Billion), 2023-2028
6. Global Exocrine Pancreatic Insufficiency Treatment Historical Market: Breakup by Region (USD Billion), 2018-2022
7. Global Exocrine Pancreatic Insufficiency Treatment Market Forecast: Breakup by Region (USD Billion), 2023-2028
8. North America Exocrine Pancreatic Insufficiency Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
9. North America Exocrine Pancreatic Insufficiency Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
10. Europe Exocrine Pancreatic Insufficiency Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
11. Europe Exocrine Pancreatic Insufficiency Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Asia Pacific Exocrine Pancreatic Insufficiency Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Asia Pacific Exocrine Pancreatic Insufficiency Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Latin America Exocrine Pancreatic Insufficiency Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Latin America Exocrine Pancreatic Insufficiency Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Middle East and Africa Exocrine Pancreatic Insufficiency Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Middle East and Africa Exocrine Pancreatic Insufficiency Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Global Exocrine Pancreatic Insufficiency Treatment Market Structure
Key Questions Answered in the Report
The global exocrine pancreatic insufficiency treatment market attained a value of more than USD 3.6 billion in 2021.
The market is projected to grow at a CAGR of 8.27% in the forecast period of 2023-2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach above USD 5.8 billion by 2027.
The market is being driven by the increasing prevalence of exocrine pancreatic insufficiency causing disorders including cystic fibrosis and diabetes, owing to sedentary lifestyles and unhealthy diets.
The market is expected to be determined by the development of effective treatments as a result of robust expenditure on pharmaceutical research and development.
The major regional markets for exocrine pancreatic insufficiency treatment are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
What are the significant types of disease management of exocrine pancreatic insufficiency treatment?
The significant types of disease management of exocrine pancreatic insufficiency treatment are nutritional management, pancreatic enzyme replacement therapy (PERT), and lifestyle modifications approach.
The major diagnostics of exocrine pancreatic insufficiency treatment are magnetic resonance imaging (MRI), CT scanning, endoscopic ultra-sonography (EUS), and blood tests, among others.
The major players in the industry are AbbVie Inc., Janssen Global Services, LLC, Chiesi Farmaceutici S.p.A., Nordmark Arzneimittel GmbH and Co. KG, Digestive Care, Inc, Cilian AG, Anthera Pharmaceuticals, Inc., Allergan plc., First Wave BioPharma, Inc. (AzurRx), and Aptalis Pharma Inc., among others.
Analyst Review
The global exocrine pancreatic insufficiency treatment market attained a value of more than USD 3.6 billion in 2021, driven by rising prevalence of EPI causing disorders. Aided by robust investments in pharmaceutical R&D, the market is expected to grow at a CAGR of 8.27% in the forecast period of 2023-2028 to reach above USD 5.8 billion by 2027.
EMR’s meticulous research methodology delves deep into the market covering the macro and micro aspects of the industry. On the basis of disease management, the market can be divided into nutritional management, pancreatic enzyme replacement therapy (PERT), and lifestyle modifications approach. On the basis of diagnosis, the market can be categorised into magnetic resonance imaging (MRI), CT scanning, endoscopic ultra-sonography (EUS), and blood tests, among others. The major regional markets for exocrine pancreatic insufficiency treatment are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa. The key players in the industry are AbbVie Inc., Janssen Global Services, LLC, Chiesi Farmaceutici S.p.A., Nordmark Arzneimittel GmbH and Co. KG, Digestive Care, Inc, Cilian AG, Anthera Pharmaceuticals, Inc., Allergan plc., First Wave BioPharma, Inc. (AzurRx), and Aptalis Pharma Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER